Q2-2019 Dermatology Update

Transaction volume within dermatology was once again driven by robust add-on acquisition activity as another quarter closed with a plethora of strategic acquisitions. Scarcity of sizable groups with which to invest, paired with an abundance of private-equity backed organizations competing for deals has contributed greatly to a landscape dominated by strategic consolidation activity. One notable and unique transaction completed in the second quarter was that of Rush University Medical Center’s (RUMC) investment in private equity-backed Pinnacle Dermatology. In acquiring a minority stake in the sponsor-backed dermatology platform, RUMC is one of the first hospital systems to transact with a private equity firm within the dermatology sector. Provident expects more and more private equity firms to take on further outside investment and/or exit to the next echelon of financial and strategic acquirers.

To print and download the full Dermatology Update report, please click below…


Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.
  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”